Results of the INPULSIS-ON extension study suggest that nintedanib has a manageable long-term safety profile and may slow the progression of idiopathic pulmonary fibrosis.
11-10-2018 | Asthma | News | Article
Results of a real-world study suggest that changing from a dry powder inhaler to a pressurized metered-dose inhaler is not associated with compromised treatment outcomes among patients with asthma.
J Allergy Clin Immunol Pract 2018; doi:10.1016/j.jaip.2018.09.027
04-10-2018 | Respiratory | News | Article
In 5-year-old children with cystic fibrosis, positivity for Aspergillus species in bronchoalveolar lavage cultures is associated with air trapping but not with bronchiectasis or reduced lung function, indicates a longitudinal study.
Thorax 2018; doi:10.1136/thoraxjnl-2018-211550
03-10-2018 | Asthma | News | Article
Systemic corticosteroid treatment reduces blood eosinophil counts and low levels are maintained for weeks after treatment is discontinued, show real-world data.
J Asthma 2018; doi:10.1080/02770903.2018.1502301
06-09-2018 | Asthma | News | Article
A single blood eosinophil count could predict persistent eosinophilia in patients with adult-onset asthma, study findings show.
Respir Med 2018; 141: 81–86